Report : Europe Butterfly Needles Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Application (Blood Collection, IV Rehydration, Delivery of Medications, Venipuncture, and Blood Transfusion) and End User (Hospitals, Clinics, Blood Banks, and Others)
At 7.9% CAGR, the Europe Butterfly Needles Market is speculated to be worth US$ 74.62 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Europe butterfly needles market was valued at US$ 47.23 million in 2022 and is expected to reach US$ 74.62 million by 2028, registering a CAGR of 7.9% from 2022 to 2028. Rise in prevalence of chronic diseases and advantages of butterfly needles over straight needles are the critical factors attributed to the Europe butterfly needles market expansion.
Butterfly needles are widely preferred to straight needles as they are highly flexible during angled insertion, less painful, and highly accurate. Also, the phlebotomist may have a close grip on the needle and precision while placing it in the vein due to their bilateral wings and a short length. Butterfly needles can be efficiently used on people with small or rolling veins and are also effective for the tiny veins of body parts such as the hand, foot, scalp, or heel. Over the years, newer models of butterfly needles have been launched into the market, providing various advantages over the other types of needles. The latest models of butterfly needles have a slide-and-lock sheath that automatically slides over the needle as it is extracted from a vein. This prevents needlestick injuries and the reuse of a used needle. For instance, VACUETTE EVOPROTECT butterfly needles developed by Greiner Group AG are equipped with mechanisms that provide semi-automatic retraction of the needle from the vein, which minimizes the risk of needlestick injury. Furthermore, the company reported that the semi-automatic safety feature is more effective at preventing NSIs than devices with manually activated mechanisms. Devices with semi-automatic safety features also resulted in lower needlestick injuries than manually activated mechanism devices. Thus, the advantages of butterfly needles over other types of needles are boosting the demand for butterfly needles, fueling the growth of the Europe butterfly needles market.
On the contrary, risk associated with butterfly needlestick injuries hurdles the growth of Europe butterfly needles market.
Based on application, the Europe butterfly needles market is segmented into blood collection, IV rehydration, delivery of medications, venipuncture, and blood transfusion. The blood collection segment held 33.9% market share in 2022, amassing US$ 16.01 million. It is projected to garner US$ 24.89 million by 2028 to expand at 7.6% CAGR during 2022–2028.
Based on end user, the Europe butterfly needles market is segmented into hospitals, clinics, blood banks, and others. The hospitals segment held 38.5% market share in 2022, amassing US$ 18.18 million. It is projected to garner US$ 29.94 million by 2028 to expand at 8.7% CAGR during 2022–2028.
Based on country, the Europe butterfly needles market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 28.2% market share in 2022. It was assessed at US$ 13.33 million in 2022 and is likely to hit US$ 21.98 million by 2028, exhibiting a CAGR of 8.7% during the forecast period.
Key players dominating the Europe butterfly needles market are B. Braun SE, Becton Dickinson and Co, Cardinal Health Inc, ICU Medical Inc, Medline Industries Inc, Nipro Corp, SB-Kawasumi Laboratories Inc, Terumo Corp, and Vogt Medical Vertrieb GmbH among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org